Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: The potential of oral insecticides in malaria control

Journal of Infectious Diseases

Volumn 202, Issue 1, 2010, Pages 113-116

  Chaccour, Carlos ^a   Lines, Jo ^a   Whitty, Christopher J M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IVERMECTIN; INSECTICIDE;

ADULT; AFRICA; ANIMAL EXPERIMENT; ANOPHELES GAMBIAE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CARRIER; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALARIA; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SURVIVAL RATE; ANIMAL; METHODOLOGY; MIDDLE AGED; MOSQUITO; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ADULT; ANIMALS; ANOPHELES GAMBIAE; FEMALE; HUMANS; INSECTICIDES; IVERMECTIN; MALARIA; MALE; MIDDLE AGED; MOSQUITO CONTROL; YOUNG ADULT;

EID: 77953713593     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/653208     Document Type: Article

References (15)

1. Girod R, Gaborit P, Carinci R, et al. Anopheles darlingi bionomics and transmission of Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae in Amerindian villages of the Upper-Maroni Amazonian forest, French Guiana. Mem Inst Oswaldo Cruz 2008; 103: 702-710.
2. Antonio-Nkondjio C, Kerah CH, Simard F, et al. Complexity of the malaria vectorial system in Cameroon: contribution of secondary vectors to malaria transmission. J Med Entomol 2006; 43: 1215-1221. (Pubitemid 44862956)
3. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009; 361 (5): 455-467.
4. Omura S, Crump A. The life and times of ivermectin-a success story. Nat Rev Microbiol 2004; 2: 984-989. (Pubitemid 39562537)
5. Guzzo CA, Furtek CI, Porras AG, et al. Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 2002; 42: 1122-1133.
6. De Sole G, Remme J, Awadzi K, et al. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Organ 1989; 67: 707-719. (Pubitemid 20090342)
7. Twum-Danso NA. Serious adverse events following treatment with ivermectin for onchocerciasis control: a review of reported cases. Filaria J 2003; 2 (suppl 1): S3.
8. Tesh RB, Guzman H. Mortality and infertility in adult mosquitoes after the ingestion of blood containing ivermectin. Am J Trop Med Hyg 1990; 43: 229-233. (Pubitemid 20348446)
9. Gardner K, Meisch MV, Meek CL, Biven WS. Effects of ivermectin in canine blood on Anopheles quadrimaculatus, Aedes albopictus and Culex salinarius. J Am Mosq Control Assoc 1993; 9: 400-402.
10. Foley DH, Bryan JH, Lawrence GW. The potential of ivermectin to control the malaria vector Anopheles farauti. Trans R Soc Trop Med Hyg 2000; 94: 625-628.
11. Bockarie MJ, Hii JL, Alexander ND, et al. Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival. Med Vet Entomol 1999; 13: 120-123.
12. Donner A, Klar N. Methods for comparing event rates in intervention studies when the unit of allocation is a cluster. Am J Epidemiol 1994; 140: 279-289; discussion 300-301.
13. Gonzalez Canga A, Sahagun Prieto AM, Diez Liebana MJ, et al. The pharmacokinetics and interactions of ivermectin in humans - a minireview. AAPS J 2008; 10: 42-46.
14. Edwards G, Dingsdale A, Helsby N, Orme ML, Breckenridge AM. The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution. Eur J Clin Pharmacol 1988; 35: 681-684. (Pubitemid 19000290)
15. Gabaldon A. What can and cannot be achieved with conventional antimalaria measures. Am J Trop Med Hyg 1978; 27: 653-658. (Pubitemid 8398068)